Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > TSH-releasing hormone for Sale > Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1
Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1 buy - large image1
Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1 buy - image1
Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1 buy - image2
Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1 buy - image3
Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1 buy - image4
Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1 buy - image5
Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1 buy - image6

Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1

TDS 7 Inquiries

Unit Price:

$50-51/UNIT FOB

Get Latest Price
CAS No.:

24305-27-9

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Generic

Packaging:

20mg/Vial

Price valid (until):

2026-10-10

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Elare

    Whatsapp:+852 5535 7215

    Please add me for our latest price list and COA


      Product Detail  



    BR20 20mg – Product Description

    Product Overview

    BR20 20mg is a commercial product supplied according to the applicable product specification and quality requirements. The product is identified by the product code BR20 and the specified quantity of 20 mg. Detailed chemical identity, composition, physical and chemical properties, purity, grade, packaging configuration, and other technical parameters should always be confirmed against the manufacturer's current product documentation.

    This product description is intended to provide general information for product identification, technical communication, and preliminary supplier evaluation. It should be read together with the applicable product specification, Certificate of Analysis (COA), Safety Data Sheet (SDS), product label, and other official documentation supplied for the relevant product and batch.

    The information presented here does not replace official safety documentation, regulatory assessment, or professional technical advice. Customers should independently confirm that the product is suitable and legally permitted for their intended application before purchasing, importing, exporting, storing, handling, processing, or distributing the product.

    Product Identification

    Product Name: BR20 20mg
    Product Code: BR20
    Quantity: 20 mg
    Product Form: According to the actual supplied product
    Grade: According to the manufacturer's applicable specification
    Packaging: According to the actual packaging configuration
    Origin: To be confirmed according to the actual supply arrangement
    Manufacturer/Supplier: To be confirmed by the supplier
    CAS Number: To be provided according to the confirmed chemical identity
    Molecular Formula: To be provided where applicable
    Molecular Weight: To be provided where applicable
    Purity: According to the applicable product specification and batch COA

    The product name and identification information should correspond exactly with the physical product, packaging label, commercial documentation, and applicable regulatory documents. Customers should not rely on a product code alone when determining chemical identity or regulatory status.

    Product Characteristics

    BR20 20mg is supplied in accordance with the applicable quality and product-control procedures. Product characteristics may depend on the specific formulation, grade, production process, batch, packaging configuration, and applicable specification.

    Before use, customers should verify the relevant technical parameters against the latest official documentation. Where a specific numerical value is required, such as purity, concentration, appearance, moisture content, assay, melting point, boiling point, density, or other physical or chemical characteristics, the value should be taken from the corresponding technical specification or batch documentation rather than from a general commercial description.

    Any information not expressly confirmed by the manufacturer should be treated as subject to verification.

    Quality Control

    Quality control is an important part of the supply and evaluation process. The applicable quality requirements should be established according to the product specification and the manufacturer's quality-management procedures.

    Depending on the nature of the product, relevant quality documentation may include a Certificate of Analysis, product specification, batch information, analytical data, or other technical records.

    The COA, when available, should be reviewed together with the product identification and batch number. Customers should ensure that the documentation corresponds to the actual product supplied and does not relate to a different product, formulation, or batch.

    For applications requiring strict quality control, customers are encouraged to establish their own incoming inspection and qualification procedures in accordance with their internal requirements and applicable regulations.

    Product Documentation

    Customers requiring technical or compliance information should request the appropriate documentation before proceeding with commercial activities.

    Depending on the actual characteristics and regulatory status of BR20 20mg, relevant documents may include:

    • Product Specification
    • Certificate of Analysis (COA)
    • Safety Data Sheet (SDS), where applicable
    • Product label information
    • Packaging information
    • Transportation classification information, where applicable
    • Regulatory or compliance documentation, where applicable
    • Other supporting technical documents supplied by the manufacturer

    The availability of specific documentation may depend on the product, destination market, supplier, batch, and applicable regulatory requirements.

    Customers should review the latest available documentation before using the product or arranging transportation.

    Safety Information

    Safety information should be obtained from the applicable SDS and official product documentation. The SDS should be reviewed before handling the product, particularly by personnel responsible for receiving, storage, transportation, processing, laboratory operations, waste management, or emergency response.

    The appropriate precautions depend on the actual chemical identity and classification of the product. Therefore, this commercial description does not provide specific hazard classifications, exposure limits, emergency procedures, or personal-protective-equipment requirements unless those details have been formally confirmed in the relevant safety documentation.

    Users should follow applicable workplace safety procedures and ensure that personnel handling the product have access to the appropriate safety information.

    If the product is determined to be subject to special chemical-control requirements, all applicable handling and management procedures should be followed.

    Storage

    BR20 20mg should be stored in accordance with the manufacturer's current storage recommendations and applicable safety documentation.

    The actual storage conditions should be confirmed from the relevant SDS and product specification. Depending on the product's characteristics, factors such as temperature, humidity, light exposure, ventilation, container integrity, and compatibility with other materials may need to be considered.

    The product should remain in suitable, correctly identified packaging during storage. Containers should be kept appropriately closed and protected from conditions that may affect product quality or package integrity.

    Customers should establish storage procedures appropriate to their facilities and the product's confirmed characteristics.

    Handling

    Before handling BR20 20mg, users should review the applicable SDS and internal operating procedures. Handling should be performed by appropriately trained personnel using procedures suitable for the confirmed properties of the product.

    Avoid unauthorized modification, repackaging, relabeling, or transfer of the product where such activities may create safety or regulatory concerns.

    Any processing, formulation, dilution, combination with other substances, or other modification should only be conducted when supported by appropriate technical information and permitted by applicable requirements.

    Specific handling instructions should not be inferred solely from the product name or product code.

    Packaging

    Packaging should correspond to the actual product and its applicable transportation and storage requirements. The packaging configuration for BR20 20mg should be confirmed before shipment.

    Where special packaging, labeling, or transport requirements apply, the supplier and customer should coordinate the relevant documentation and arrangements before dispatch.

    Customers should inspect the external packaging upon receipt and verify that the product identification, quantity, packaging integrity, and accompanying documentation are consistent with the purchase order and applicable product information.

    Damaged, incorrectly labeled, or otherwise questionable packages should be handled according to the supplier's applicable procedures and relevant safety requirements.

    Transportation

    Transportation arrangements should be based on the confirmed product classification and applicable regulations in the shipping and destination jurisdictions.

    If the product is classified as dangerous goods or otherwise subject to transportation controls, the applicable packaging, labeling, documentation, carrier, and transport requirements must be followed.

    The transport status of a chemical product should not be determined solely from a commercial product name or product code. Where required, the relevant transportation classification should be confirmed using the current SDS and applicable official documentation.

    Customers and logistics providers are responsible for ensuring that transportation arrangements comply with applicable requirements.

    Regulatory Information

    The regulatory status of BR20 20mg should be evaluated according to its confirmed chemical identity, composition, concentration, intended application, country of origin, destination market, and applicable legislation.

    Different jurisdictions may apply different requirements to the same chemical product. A product may be subject to requirements concerning chemical registration, dangerous goods, hazardous chemicals, import and export controls, occupational safety, environmental protection, storage, transportation, or other regulatory controls.

    For this reason, customers should perform an appropriate regulatory review before conducting cross-border transactions.

    Where the product is subject to special regulatory controls, the supplier should provide applicable documentation where legally and commercially appropriate, and the customer should ensure that it holds any permits, registrations, licenses, or other authorizations required for its activities.

    Compliance Statement

    Product information published on a B2B marketplace should accurately represent the actual product being offered.

    The product name, specification, quantity, chemical identity, CAS number, packaging information, and other material information should be consistent with the supplier's genuine documentation.

    This listing should not be interpreted as confirmation that a particular customer, application, transaction, importation, exportation, or distribution activity is legally permitted.

    The supplier and customer are each responsible for complying with the laws and regulations applicable to their respective activities and jurisdictions.

    Where documentation or qualification is required before listing or trading a product, the relevant documentation should be completed and submitted through the applicable platform or regulatory process before commercial activity proceeds.

    No information should be intentionally omitted, altered, disguised, or presented in a misleading manner for the purpose of bypassing platform review or regulatory requirements.

    Intended Application

    BR20 20mg should only be used for applications that are supported by the manufacturer's documentation and permitted under applicable laws and regulations.

    Any specific application claim should be supported by appropriate technical evidence. The supplier should avoid representing the product as suitable for a particular industry, process, formulation, or end use unless such representation can be substantiated.

    Customers should evaluate product compatibility, technical suitability, safety requirements, and regulatory status before use.

    Where the intended application involves additional regulatory requirements, customers should obtain appropriate professional advice and complete the required qualification process.

    Customer Responsibilities

    Before ordering BR20 20mg, customers should verify:

    1. The exact product identity and specification.
    2. The applicable quantity and packaging configuration.
    3. The latest available technical documentation.
    4. The applicable SDS and safety information.
    5. The regulatory status in the destination market.
    6. Any required import, export, storage, handling, or transportation authorization.
    7. The suitability of the product for the customer's intended application.
    8. The compatibility of the product with the customer's facilities and operating procedures.
    9. The applicable requirements for waste management and disposal.
    10. Any additional requirements imposed by local authorities or internal compliance procedures.

    Customers should retain appropriate purchasing and product documentation for their internal records where required.

    Supplier Information

    The supplier should provide accurate information concerning the products actually offered for sale. Any statement concerning quality, specification, documentation, availability, packaging, or compliance should be based on information that can be verified.

    Where a customer requests additional technical documentation, the supplier may provide the applicable documents subject to confidentiality, commercial policy, and legal requirements.

    Product documentation should be kept current, and outdated information should not be used when a newer official document is available.

    Notice Regarding Product Information

    This product description provides general commercial information and is not intended to replace the official product specification or SDS.

    Because regulatory requirements and product documentation may change, customers should obtain the latest applicable information before placing an order, arranging shipment, or using the product.

    Any technical value, classification, application statement, or regulatory claim should be verified against official documentation before publication.

    If there is any inconsistency between this general description and the manufacturer's official technical or safety documentation, the official documentation should take precedence.

    Final Product Verification

    Before publishing BR20 20mg on a marketplace, the supplier should verify the complete product information, including the actual chemical name, CAS number where applicable, composition, specification, packaging, safety documentation, and regulatory status.

    If the product falls within a regulated or restricted category, the supplier should first confirm that the necessary qualifications and permissions are available and applicable to the specific product and business activity.

    If required documentation has not yet been submitted or verified, the product should remain subject to the platform's review process rather than being described in a manner intended to avoid review.

    The objective of this product page is to provide clear, accurate, and professionally presented information that allows customers and compliance teams to evaluate the product based on genuine documentation.

    BR20 20mg should be supplied, handled, transported, stored, and used only in accordance with the applicable product documentation, safety requirements, and laws and regulations.


    1.  

    Items Specifications
    Product Name BR20
    Grade Research Grade
    Package 20mg/Vial
    Appearance White Lyophilized Powder
    Model BR20 20mg
    Brand Generic

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 1

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 2
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 3
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 4
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 5
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 6
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 7
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 8
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 9
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 10
    ECHEMI Editorial Reference
    Protirelin is a highly conserved neuropeptide that exerts the hormonal control of thyroid-stimulating hormone (TSH) levels as well as neuromodulatory functions.
    Protirelin is a tripeptide composed of L-pyroglutamyl, L-histidyl and L-prolinamide residues joined in sequence. It has a role as a human metabolite. It is a peptide hormone and a tripeptide.|Protirelin is the pharmaceutically available synthetic analogue of the endogenous peptide thyrotropin-releasing hormone (TRH). It is a tri-peptide tropic hormone, released by the hypothalamus, that stimulates the release of Thyroid Stimulating Hormone (TSH) and prolactin from the anterior pituitary. Although not currently available in any FDA-approved product, protirelin is a component of the TRH Test where it is used to test the response of the anterior pituitary gland in conditions such as secondary hypothyroidism and acromegaly.|A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND.
    Research & Reference Note

    Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1 is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Certificates
    • Bronchogen BR20 hot sale safe delivery HIGH purity product peptide 1 Certificates 1 TDS

    Basic Info
    Product Name:

    TSH-releasing hormone

    Other Name:

    L-Prolinamide,5-oxo-L-prolyl-L-histidyl-;Thyrotropin-releasing factor;5-Oxo-L-prolyl-L-histidyl-L-prolinamide;L-Pyroglutamyl-L-histidyl-L-prolinamide;L-Pyroglutamyl-L-histidyl-L-proline amide;Synthetic TRH;Synthetic thyrotropin-releasing hormone;(Pyro)-L-glutamic acid-L-histidine-L-proline-NH2;Synthetic TSH-releasing hormone;Synthetic TSH-releasing factor;Synthetic thyrotropin-releasing factor;Lopremone;FDA 1725;Synthetic TRF;Protirelin;TSH-releasing factor;Thyroliberin;TRH;TRF;Thyrotropin-releasing hormone;Thyrotropic hormone-releasing factor;TSH-releasing hormone;Thyrotropic hormone-releasing hormone;Thyrotropic-releasing factor;TSH-RF;Thyroid-stimulating hormone-releasing factor;Thyrotropic releasing hormone;Rifathyroin;Ro 8-6270/9;Thyroid releasing hormone;Relefact TRH;Thyrefact;Rifotironin;Antepan;Prem;Thypinone;Stimu TSH;Abbott 38579;83: PN: US20090175821 PAGE: 403 claimed protein;252: PN: WO2010033207 SEQID: 378 claimed protein;9015-91-2;22365-17-9;22365-02-2;39422-15-6;77666-61-6

    CAS No.:

    24305-27-9

    Molecular Formula:

    C16H22N6O4

    InChIKeys:

    InChIKey=XNSAINXGIQZQOO-SRVKXCTJSA-N

    Molecular Weight:

    362.38

    Exact Mass:

    362.38

    EC Number:

    246-143-4

    UNII:

    5Y5F15120W

    DSSTox ID:

    DTXSID0023533

    ATC Code:

    V - Various

    Characteristics
    PSA:

    150

    XLogP3:

    -2.43

    Appearance:

    powder

    Density:

    1.5±0.1 g/cm3

    Boiling Point:

    942.1±65.0 °C at 760 mmHg

    Flash Point:

    523.6±34.3 °C

    Refractive Index:

    1.617

    Water Solubility:

    H2O: 10 mg/mL, clear, colorless

    Storage Conditions:

    −20°C

    Vapor Pressure:

    0mmHg at 25°C

    Collision Cross Section:

    181 Ų [M+H]+ [CCS Type: DT, Method: stepped-field]|184.12 Ų [M+Na]+ [CCS Type: DT, Method: stepped-field]|187.07 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|179.2 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|182.4 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|184.5 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|183.2 Ų [M+Na-2H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|183.2 Ų [M-2H+Na]-

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Inhalation

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H332 Harmful if inhaled

    Precautionary statement(s)
    Prevention

    P261 Avoid breathing dust/fume/gas/mist/vapours/spray.

    P271 Use only outdoors or in a well-ventilated area.

    Response

    P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

    P317 Get medical help.

    Storage

    none

    Disposal

    none

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Y17, Room 310, East Third Floor, No. 64 and 66 Jianzhong Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Employees:

    11-50

    Year of Establishment:

    2026

    Founded in 2024, PGpeptides is a specialized supplier of high-purity
    research peptides serving the global scientific community. With deep
    industry expertise, we deliver consistent product quality, competitive
    pricing, and flexible service tailored to research institutions, laboratories,
    and distributors worldwide.
    Our operations span North America, Europe, Asia, Australia, and the
    Middle East, backed by a mature international trade infrastructure and a
    reliable global fulfillment network. We have earned strong recognition 
    and trust across the markets we serve.
  • Inquiry History
    7 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    TRH Thyrotropin

    10 MT Mar 5, 2026
    Italy

    Thyrotropin

    200 MG Nov 22, 2024
    Netherlands

    Livagen

    1 G Apr 26, 2026
    United States

    TRH (Thyrotropin-Releasing Hormone)

    20 MG Jul 23, 2025
    Thailand

    Bronchogen

    100  Apr 23, 2025
    Italy

    Protirelin

    100 MG Nov 7, 2024
    United States

    Protirelin Acetate

    10 KG Nov 15, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.